FAM162A and chronic obstructive pulmonary disease: By RT-qPCR, five biomarkers, BCL2, CCR7, FAM162A, FOXO1, and RPS3, were notably downregulated in COPD and expression trends were consistent with GSE94916 and GSE42057 datasets (Figure 9).